Metal-Based Complexes in Cancer
- PMID: 37108457
- PMCID: PMC10138440
- DOI: 10.3390/ijms24087289
Metal-Based Complexes in Cancer
Abstract
Metal-based drugs have attracted growing interest in biomedicine [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Metal Complexes in Cancer Treatment: Journey So Far.Chem Biodivers. 2023 Apr;20(4):e202300061. doi: 10.1002/cbdv.202300061. Epub 2023 Mar 13. Chem Biodivers. 2023. PMID: 36824028 Review.
-
Multi-Target Metal-Based Anticancer Agents.Curr Top Med Chem. 2017 Nov 20;17(28):3131-3145. doi: 10.2174/1568026617666171004155437. Curr Top Med Chem. 2017. PMID: 28982336 Review.
-
Fluorescent metal-based complexes as cancer probes.Bioorg Med Chem Lett. 2020 Jul 1;30(13):127219. doi: 10.1016/j.bmcl.2020.127219. Epub 2020 Apr 28. Bioorg Med Chem Lett. 2020. PMID: 32360103 Review.
-
Transition metals and metal complexes in autophagy and diseases.J Cell Physiol. 2021 Oct;236(10):7144-7158. doi: 10.1002/jcp.30359. Epub 2021 Mar 10. J Cell Physiol. 2021. PMID: 33694161 Review.
-
Metal complexes in medicine and pharmacy - the past and the present II.Ceska Slov Farm. 2020 Winter;69(1):3-16. Ceska Slov Farm. 2020. PMID: 32460505 Review. English.
Cited by
-
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs.Int J Mol Sci. 2023 Aug 1;24(15):12296. doi: 10.3390/ijms241512296. Int J Mol Sci. 2023. PMID: 37569672 Free PMC article. Review.
-
Crystal Design, Antitumor Activity and Molecular Docking of Novel Palladium(II) and Gold(III) Complexes with a Thiosemicarbazone Ligand.Int J Mol Sci. 2023 Jul 14;24(14):11442. doi: 10.3390/ijms241411442. Int J Mol Sci. 2023. PMID: 37511201 Free PMC article.
-
Metal-based molecules in the treatment of cancer: From bench to bedside.Oncol Res. 2025 Mar 19;33(4):759-779. doi: 10.32604/or.2024.057019. eCollection 2025. Oncol Res. 2025. PMID: 40191719 Free PMC article. Review.
References
-
- Anthony E.J., Bolitho E.M., Bridgewater H.E., Carter O.W.L., Donnelly J.M., Imberti C., Lant E.C., Lermyte F., Needham R.J., Palau M., et al. Metallodrugs are unique: Opportunities and challenges of discovery and development. Chem. Sci. 2020;11:12888–12917. doi: 10.1039/D0SC04082G. - DOI - PMC - PubMed
-
- Paprocka R., Wiese-Szadkowska M., Janciauskiene S., Kosmalski T., Kulik M., Helmin-Basa A. Latest developments in metal complexes as anticancer agents. Coord. Chem. Rev. 2022;452:214307. doi: 10.1016/j.ccr.2021.214307. - DOI
-
- Vértiz G., García-Ortuño L.E., Bernal J.P., Bravo-Gómez M.E., Lounejeva E., Huerta A., Ruiz-Azuara L. Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: Casiopeina III-Ea, after a single intravenous dose in rats. Fundam. Clin. Pharmacol. 2014;28:78–87. doi: 10.1111/j.1472-8206.2012.01075.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical